Table 2 |
||||||
|
Analysis of flow cytometric cell cycle distribution before and after exposure to gemcitabine (0.3 μM) a. |
||||||
|
RL-7 |
RL-G |
|||||
|
|
||||||
|
Control |
24 h |
72 h |
Control |
24 h |
72 h |
|
|
|
|
|||||
|
G1 |
53.2 ± 9.0 |
63.3 ± 1.5 |
15.0 ± 1.4 |
39.7 ± 7.5 |
38.2 ± 6.4 |
40.9 ± 2.6 |
|
S |
39.2 ± 3.0 |
36.5 ± 1.3 |
84.7 ± 1.4 |
46.3 ± 10.6 |
50.3 ± 8.5 |
51.6 ± 1.4 |
|
G2/M |
7.4 ± 6.1 |
0.3 ± 0.1 |
0.2 ± 0.3 |
13.8 ± 3.2 |
11.2 ± 2.2 |
7.2 ± 1.4 |
|
|
||||||
|
a The reported values (mean ± SD, n = 3) are expressed as percentage of total cells. |
||||||
|
Galmarini et al. BMC Pharmacology 2004 4:8 doi:10.1186/1471-2210-4-8 |
||||||
